GUIDE TO ANTICOAGULANT-THERAPY .1. HEPARIN

[1] HIGHLY PURIFIED ANTITHROMBIN 3 WITH HEPARIN COFACTOR ACTIVITY PREPARED BY DISC ELECTROPHORESIS [J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1968, 21 (01) : 89 - +

[2] AGNELLI G, 1990, THROMB HAEMOSTASIS, V63, P204

[3] TREATMENT OF ACUTE VENOUS THROMBOEMBOLISM WITH LOW-MOLECULAR WEIGHT HEPARIN (FRAGMIN) - RESULTS OF A DOUBLE-BLIND RANDOMIZED STUDY [J]. CIRCULATION, 1989, 80 (04) : 935 - 940

[4] A POPULATION-BASED PERSPECTIVE OF THE HOSPITAL INCIDENCE AND CASE-FATALITY RATES OF DEEP-VEIN THROMBOSIS AND PULMONARY-EMBOLISM - THE WORCESTER DVT STUDY [J]. ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (05) : 933 - 938

[5] SUBCUTANEOUS ADMINISTRATION OF HEPARIN - A RANDOMIZED COMPARISON WITH INTRAVENOUS ADMINISTRATION OF HEPARIN TO PATIENTS WITH DEEP-VEIN THROMBOSIS [J]. THROMBOSIS RESEARCH, 1982, 27 (06) : 631 - 639

[6] MOLECULAR-WEIGHT DEPENDENCY OF THE HEPARIN POTENTIATED INHIBITION OF THROMBIN AND ACTIVATED FACTOR-X - EFFECT OF HEPARIN NEUTRALIZATION IN PLASMA [J]. THROMBOSIS RESEARCH, 1979, 15 (3-4) : 531 - 541

[7] ANTICOAGULANT PROPERTIES OF HEPARIN FRACTIONATED BY AFFINITY CHROMATOGRAPHY ON MATRIX-BOUND ANTITHROMBIN-3 AND BY GEL-FILTRATION [J]. THROMBOSIS RESEARCH, 1976, 9 (06) : 575 - 583

[8] ANDRIUOLI G, 1985, HAEMOSTASIS, V15, P324

[9] [Anonymous], 1988, LANCET, V2, P349

[10] [Anonymous], 1990, Lancet, V336, P65

[1] HIGHLY PURIFIED ANTITHROMBIN 3 WITH HEPARIN COFACTOR ACTIVITY PREPARED BY DISC ELECTROPHORESIS [J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1968, 21 (01) : 89 - +

[2] AGNELLI G, 1990, THROMB HAEMOSTASIS, V63, P204

[3] TREATMENT OF ACUTE VENOUS THROMBOEMBOLISM WITH LOW-MOLECULAR WEIGHT HEPARIN (FRAGMIN) - RESULTS OF A DOUBLE-BLIND RANDOMIZED STUDY [J]. CIRCULATION, 1989, 80 (04) : 935 - 940

[4] A POPULATION-BASED PERSPECTIVE OF THE HOSPITAL INCIDENCE AND CASE-FATALITY RATES OF DEEP-VEIN THROMBOSIS AND PULMONARY-EMBOLISM - THE WORCESTER DVT STUDY [J]. ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (05) : 933 - 938

[5] SUBCUTANEOUS ADMINISTRATION OF HEPARIN - A RANDOMIZED COMPARISON WITH INTRAVENOUS ADMINISTRATION OF HEPARIN TO PATIENTS WITH DEEP-VEIN THROMBOSIS [J]. THROMBOSIS RESEARCH, 1982, 27 (06) : 631 - 639

[6] MOLECULAR-WEIGHT DEPENDENCY OF THE HEPARIN POTENTIATED INHIBITION OF THROMBIN AND ACTIVATED FACTOR-X - EFFECT OF HEPARIN NEUTRALIZATION IN PLASMA [J]. THROMBOSIS RESEARCH, 1979, 15 (3-4) : 531 - 541

[7] ANTICOAGULANT PROPERTIES OF HEPARIN FRACTIONATED BY AFFINITY CHROMATOGRAPHY ON MATRIX-BOUND ANTITHROMBIN-3 AND BY GEL-FILTRATION [J]. THROMBOSIS RESEARCH, 1976, 9 (06) : 575 - 583

[8] ANDRIUOLI G, 1985, HAEMOSTASIS, V15, P324

[9] [Anonymous], 1988, LANCET, V2, P349

[10] [Anonymous], 1990, Lancet, V336, P65